Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Levoamlodipine market was valued at US$ 36630 million in 2022 and is projected to reach US$ 75160 million by 2029, at a CAGR of 10.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hypertension is a common cardiovascular disease affecting a large proportion of the global population. The increasing prevalence of hypertension worldwide is driving the demand for effective antihypertensive drugs such as S-amlodipine.
Levoamlodipine can effectively control 24-hour blood pressure, especially at night blood pressure control has unique advantages, it can also effectively prevent the sudden rise of blood pressure in the morning, reduce the sharp rise and fall of blood pressure, so as to effectively maintain the blood flow of important organs and protect the function of target organs.
This report aims to provide a comprehensive presentation of the global market for Levoamlodipine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Levoamlodipine. This report contains market size and forecasts of Levoamlodipine in global, including the following market information:
Global Levoamlodipine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Levoamlodipine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Levoamlodipine companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Levoamlodipine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Levoamlodipine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Levoamlodipine Market Segment Percentages, by Type, 2022 (%)
Amlodipine Besylate Tablets
Amlodipine Mesylate Tablets
Amlodipine Maleate Tablets
Global Levoamlodipine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Levoamlodipine Market Segment Percentages, by Application, 2022 (%)
Hypertension
Angina pectoris
Global Levoamlodipine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Levoamlodipine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Levoamlodipine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Levoamlodipine revenues share in global market, 2022 (%)
Key companies Levoamlodipine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Levoamlodipine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aristo Pharmaceuticals Pvt Ltd
Novartis
Pfizer
Lek
TEVA
Macleods Pharmaceuticals
Caraco Pharmaceutical
Sanis Health
Jamp Pharma
Accel Pharma
Jubilant Generics
Angita Pharma
Florida DOH Central Pharmacy
Chengdu Di'ao Pharmaceutical Group Co., Ltd.
Yangzijiang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Levoamlodipine, market overview.
Chapter 2: Global Levoamlodipine market size in revenue and volume.
Chapter 3: Detailed analysis of Levoamlodipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Levoamlodipine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Levoamlodipine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Levoamlodipine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Levoamlodipine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Levoamlodipine Overall Market Size
2.1 Global Levoamlodipine Market Size: 2022 VS 2029
2.2 Global Levoamlodipine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Levoamlodipine Sales: 2018-2029
3 Company Landscape
3.1 Top Levoamlodipine Players in Global Market
3.2 Top Global Levoamlodipine Companies Ranked by Revenue
3.3 Global Levoamlodipine Revenue by Companies
3.4 Global Levoamlodipine Sales by Companies
3.5 Global Levoamlodipine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Levoamlodipine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Levoamlodipine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Levoamlodipine Players in Global Market
3.8.1 List of Global Tier 1 Levoamlodipine Companies
3.8.2 List of Global Tier 2 and Tier 3 Levoamlodipine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Levoamlodipine Market Size Markets, 2022 & 2029
4.1.2 Amlodipine Besylate Tablets
4.1.3 Amlodipine Mesylate Tablets
4.1.4 Amlodipine Maleate Tablets
4.2 By Type - Global Levoamlodipine Revenue & Forecasts
4.2.1 By Type - Global Levoamlodipine Revenue, 2018-2023
4.2.2 By Type - Global Levoamlodipine Revenue, 2024-2029
4.2.3 By Type - Global Levoamlodipine Revenue Market Share, 2018-2029
4.3 By Type - Global Levoamlodipine Sales & Forecasts
4.3.1 By Type - Global Levoamlodipine Sales, 2018-2023
4.3.2 By Type - Global Levoamlodipine Sales, 2024-2029
4.3.3 By Type - Global Levoamlodipine Sales Market Share, 2018-2029
4.4 By Type - Global Levoamlodipine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Levoamlodipine Market Size, 2022 & 2029
5.1.2 Hypertension
5.1.3 Angina pectoris
5.2 By Application - Global Levoamlodipine Revenue & Forecasts
5.2.1 By Application - Global Levoamlodipine Revenue, 2018-2023
5.2.2 By Application - Global Levoamlodipine Revenue, 2024-2029
5.2.3 By Application - Global Levoamlodipine Revenue Market Share, 2018-2029
5.3 By Application - Global Levoamlodipine Sales & Forecasts
5.3.1 By Application - Global Levoamlodipine Sales, 2018-2023
5.3.2 By Application - Global Levoamlodipine Sales, 2024-2029
5.3.3 By Application - Global Levoamlodipine Sales Market Share, 2018-2029
5.4 By Application - Global Levoamlodipine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Levoamlodipine Market Size, 2022 & 2029
6.2 By Region - Global Levoamlodipine Revenue & Forecasts
6.2.1 By Region - Global Levoamlodipine Revenue, 2018-2023
6.2.2 By Region - Global Levoamlodipine Revenue, 2024-2029
6.2.3 By Region - Global Levoamlodipine Revenue Market Share, 2018-2029
6.3 By Region - Global Levoamlodipine Sales & Forecasts
6.3.1 By Region - Global Levoamlodipine Sales, 2018-2023
6.3.2 By Region - Global Levoamlodipine Sales, 2024-2029
6.3.3 By Region - Global Levoamlodipine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Levoamlodipine Revenue, 2018-2029
6.4.2 By Country - North America Levoamlodipine Sales, 2018-2029
6.4.3 US Levoamlodipine Market Size, 2018-2029
6.4.4 Canada Levoamlodipine Market Size, 2018-2029
6.4.5 Mexico Levoamlodipine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Levoamlodipine Revenue, 2018-2029
6.5.2 By Country - Europe Levoamlodipine Sales, 2018-2029
6.5.3 Germany Levoamlodipine Market Size, 2018-2029
6.5.4 France Levoamlodipine Market Size, 2018-2029
6.5.5 U.K. Levoamlodipine Market Size, 2018-2029
6.5.6 Italy Levoamlodipine Market Size, 2018-2029
6.5.7 Russia Levoamlodipine Market Size, 2018-2029
6.5.8 Nordic Countries Levoamlodipine Market Size, 2018-2029
6.5.9 Benelux Levoamlodipine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Levoamlodipine Revenue, 2018-2029
6.6.2 By Region - Asia Levoamlodipine Sales, 2018-2029
6.6.3 China Levoamlodipine Market Size, 2018-2029
6.6.4 Japan Levoamlodipine Market Size, 2018-2029
6.6.5 South Korea Levoamlodipine Market Size, 2018-2029
6.6.6 Southeast Asia Levoamlodipine Market Size, 2018-2029
6.6.7 India Levoamlodipine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Levoamlodipine Revenue, 2018-2029
6.7.2 By Country - South America Levoamlodipine Sales, 2018-2029
6.7.3 Brazil Levoamlodipine Market Size, 2018-2029
6.7.4 Argentina Levoamlodipine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Levoamlodipine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Levoamlodipine Sales, 2018-2029
6.8.3 Turkey Levoamlodipine Market Size, 2018-2029
6.8.4 Israel Levoamlodipine Market Size, 2018-2029
6.8.5 Saudi Arabia Levoamlodipine Market Size, 2018-2029
6.8.6 UAE Levoamlodipine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Aristo Pharmaceuticals Pvt Ltd
7.1.1 Aristo Pharmaceuticals Pvt Ltd Company Summary
7.1.2 Aristo Pharmaceuticals Pvt Ltd Business Overview
7.1.3 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Major Product Offerings
7.1.4 Aristo Pharmaceuticals Pvt Ltd Levoamlodipine Sales and Revenue in Global (2018-2023)
7.1.5 Aristo Pharmaceuticals Pvt Ltd Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Levoamlodipine Major Product Offerings
7.2.4 Novartis Levoamlodipine Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Levoamlodipine Major Product Offerings
7.3.4 Pfizer Levoamlodipine Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Lek
7.4.1 Lek Company Summary
7.4.2 Lek Business Overview
7.4.3 Lek Levoamlodipine Major Product Offerings
7.4.4 Lek Levoamlodipine Sales and Revenue in Global (2018-2023)
7.4.5 Lek Key News & Latest Developments
7.5 TEVA
7.5.1 TEVA Company Summary
7.5.2 TEVA Business Overview
7.5.3 TEVA Levoamlodipine Major Product Offerings
7.5.4 TEVA Levoamlodipine Sales and Revenue in Global (2018-2023)
7.5.5 TEVA Key News & Latest Developments
7.6 Macleods Pharmaceuticals
7.6.1 Macleods Pharmaceuticals Company Summary
7.6.2 Macleods Pharmaceuticals Business Overview
7.6.3 Macleods Pharmaceuticals Levoamlodipine Major Product Offerings
7.6.4 Macleods Pharmaceuticals Levoamlodipine Sales and Revenue in Global (2018-2023)
7.6.5 Macleods Pharmaceuticals Key News & Latest Developments
7.7 Caraco Pharmaceutical
7.7.1 Caraco Pharmaceutical Company Summary
7.7.2 Caraco Pharmaceutical Business Overview
7.7.3 Caraco Pharmaceutical Levoamlodipine Major Product Offerings
7.7.4 Caraco Pharmaceutical Levoamlodipine Sales and Revenue in Global (2018-2023)
7.7.5 Caraco Pharmaceutical Key News & Latest Developments
7.8 Sanis Health
7.8.1 Sanis Health Company Summary
7.8.2 Sanis Health Business Overview
7.8.3 Sanis Health Levoamlodipine Major Product Offerings
7.8.4 Sanis Health Levoamlodipine Sales and Revenue in Global (2018-2023)
7.8.5 Sanis Health Key News & Latest Developments
7.9 Jamp Pharma
7.9.1 Jamp Pharma Company Summary
7.9.2 Jamp Pharma Business Overview
7.9.3 Jamp Pharma Levoamlodipine Major Product Offerings
7.9.4 Jamp Pharma Levoamlodipine Sales and Revenue in Global (2018-2023)
7.9.5 Jamp Pharma Key News & Latest Developments
7.10 Accel Pharma
7.10.1 Accel Pharma Company Summary
7.10.2 Accel Pharma Business Overview
7.10.3 Accel Pharma Levoamlodipine Major Product Offerings
7.10.4 Accel Pharma Levoamlodipine Sales and Revenue in Global (2018-2023)
7.10.5 Accel Pharma Key News & Latest Developments
7.11 Jubilant Generics
7.11.1 Jubilant Generics Company Summary
7.11.2 Jubilant Generics Levoamlodipine Business Overview
7.11.3 Jubilant Generics Levoamlodipine Major Product Offerings
7.11.4 Jubilant Generics Levoamlodipine Sales and Revenue in Global (2018-2023)
7.11.5 Jubilant Generics Key News & Latest Developments
7.12 Angita Pharma
7.12.1 Angita Pharma Company Summary
7.12.2 Angita Pharma Levoamlodipine Business Overview
7.12.3 Angita Pharma Levoamlodipine Major Product Offerings
7.12.4 Angita Pharma Levoamlodipine Sales and Revenue in Global (2018-2023)
7.12.5 Angita Pharma Key News & Latest Developments
7.13 Florida DOH Central Pharmacy
7.13.1 Florida DOH Central Pharmacy Company Summary
7.13.2 Florida DOH Central Pharmacy Levoamlodipine Business Overview
7.13.3 Florida DOH Central Pharmacy Levoamlodipine Major Product Offerings
7.13.4 Florida DOH Central Pharmacy Levoamlodipine Sales and Revenue in Global (2018-2023)
7.13.5 Florida DOH Central Pharmacy Key News & Latest Developments
7.14 Chengdu Di'ao Pharmaceutical Group Co., Ltd.
7.14.1 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Company Summary
7.14.2 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Business Overview
7.14.3 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Major Product Offerings
7.14.4 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Levoamlodipine Sales and Revenue in Global (2018-2023)
7.14.5 Chengdu Di'ao Pharmaceutical Group Co., Ltd. Key News & Latest Developments
7.15 Yangzijiang Pharmaceutical
7.15.1 Yangzijiang Pharmaceutical Company Summary
7.15.2 Yangzijiang Pharmaceutical Business Overview
7.15.3 Yangzijiang Pharmaceutical Levoamlodipine Major Product Offerings
7.15.4 Yangzijiang Pharmaceutical Levoamlodipine Sales and Revenue in Global (2018-2023)
7.15.5 Yangzijiang Pharmaceutical Key News & Latest Developments
8 Global Levoamlodipine Production Capacity, Analysis
8.1 Global Levoamlodipine Production Capacity, 2018-2029
8.2 Levoamlodipine Production Capacity of Key Manufacturers in Global Market
8.3 Global Levoamlodipine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Levoamlodipine Supply Chain Analysis
10.1 Levoamlodipine Industry Value Chain
10.2 Levoamlodipine Upstream Market
10.3 Levoamlodipine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Levoamlodipine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
